SYS-CON MEDIA Authors: Mat Mathews, Newswire, David Smith, Tim Crawford, Kevin Benedict

News Feed Item

Ivera Medical Asserts New Patent Litigation Against Competitors

SAN DIEGO, CA -- (Marketwired) -- 06/10/14 -- Ivera Medical Corporation, a certified minority-owned business, announced it has filed patent infringement lawsuits against its competitors in federal court in San Diego. U.S. Patent No. 8,740,864, issued by the US Patent and Trademark Office on June 3, 2014, is owned by BD (Becton, Dickinson and Company). It had been previously announced that Ivera Medical has an exclusive license to this patent.

The lawsuits were filed against:

  • Catheter Connections (Salt Lake City, UT) for its DualCap Solo and LB IV-Pole Strip products;
  • Hospira (Lake Forest, IL) for its Lifeshield EffectIV-Cap product;
  • Excelsior Medical (Neptune, NJ) for its SwabCap, SwabFlush, SwabPack, and SwabKit products; and
  • Covidien LP and Covidien Sales LLC (Mansfield, MA) for its Kendall Disinfecting Cap products.

"When we pioneered the Port Protector market with Curos®, we secured the rights to this technology, seeing that it would serve as the seminal patent in this space," said Bob Rogers, CEO of Ivera Medical. "With the issuance of this patent, we are looking forward to protecting our significant investment in this market."

About Ivera Medical
Ivera Medical Corporation, a certified Minority Business Enterprise (MBE), is focused on the design, development, manufacture, marketing and sale of products that help healthcare providers reduce facility-acquired patient infections. Curos, manufactured in Carlsbad, CA, is the first disinfecting cap to be marketed in the U.S. and has received FDA's 510(k) market clearance. For more information about Curos and Ivera Medical, visit the website at

Matt Heindel
Vice President, Business Development
Ivera Medical Corp.

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.